Pulmonary disease due to nontuberculous mycobacteria

Chest

Volumn 133, Issue 1, 2008, Pages 243-251

  Glassroth, Jeffrey ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bronchiectasis; Hypersensitivity pneumonitis; Mycobacterium avium complex; Mycobacterium kansasii; Nontuberculous mycobacteria; Pulmonary disease; Rapidly growing mycobacteria

Indexed keywords

GAMMA INTERFERON;

ALLERGIC PNEUMONITIS; BACTERIUM IDENTIFICATION; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; HUMAN; LUNG INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; REVIEW; SMOKING; TREATMENT INDICATION;

EID: 38349049323     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0358     Document Type: Article

References (75)

1. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16:319-354
2. Falkinham JO III. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002; 23:529-551
3. Good RC, Snider DE. Isolation of nontuberculous mycobacteria in the United States. J Infect Dis 1980; 146:829-833
4. Ostroff S, Hutwagner L, Collin S. Mycobacterial species and drug resistance patterns reported by state laboratories-1992. 93rd American Society for Microbiology General Meeting, May 16, 1993, Atlanta, GA; abstract U-9:170
5. Martin-Casabona N, Bahrmand AR, Bennedsen J, et al. Non-tuberculous mycobacteria: patterns of isolation; a multi-country retrospective survey. Int J Tuberc Lung Dis 2004; 8:1186-1193
6. Kennedy MP, O'Connor TM, Ryan C, et al. Nontuberculous mycobacteria incidence in Southwest Ireland from 1987 to 2000. Respir Med 2003; 97:257-263
7. Dailloux M, Abalain ML, Laurain C, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006; 28:1211-1215
8. Wallace RJ Jr, Zhang Y, Brown BA, et al. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998; 158:1235-1244
9. Fowler SJ, French J, Screaton NJ, et al. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 2006; 1204-1210
10. American Thoracic Society/Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416
11. Hoiby N, Pressler T. Emerging pathogens in cystic fibrosis. Eur Respir Mon 2006; 35:66-78
12. McGarvey J, Bermudez LE. Pathogenesis of mycobacterial infections. Clin Chest Med 2002; 23:569-583
13. Koh WJ, Kwon J, Kim EJ. NRAMP gene polymorphism and susceptibility to nontuberculous mycobacterial disease. Chest 2005; 128:94-101
14. Hayashi T, Catanzaro A, Rao SP, Apotosis of human monocytes and macrophages by Mycobacterium avium sonicate. Infect Immun 1997; 65:5262-5271
15. Balcewicz-Sablinska MK, Gan H, Remold HG. Interleukin-10 produced in macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apotosis by reduction of TNF-α activity. J Infect Dis 1999; 180:1230-1237
16. Appelberg R, Castro AG, Pedrosa J, et al. Role of γ interferon and tumor necrosis factor α during T-cell independent and -dependent mycobacterium phases of Mycobacterium avium infection. Infection Immun 1994; 62:3962-3971
17. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:1332-1338
18. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-1949
19. Safdar A, White DA, Stover D, et al. Profound interferon γ deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am J Med 2002; 113:756-759
20. Cooke SG, Campbell SJ, Sillah J, et al. Polymorphism within the interferon-γ/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174:339-343
21. Field SK, Cowie RL. Lung disease due to more common nontuberculous mycobacteria. Chest 2006; 129:1653-1672
22. Lewis AG Jr, Dunbar FP, Lasche EM, et al. Chronic pulmonary disease due to atypical mycobacterial infections. Am Rev Respir Dis 1959; 80:188-199
23. Iseman MO, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis: thoracic abnormalities associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991; 144:914-916
24. Christensen EE, Dietz GW, Ann CH, et al. Pulmonary manifestations of Mycobacterium intracellulare. AJR Am J Roentgenol 1979; 133:59-66
25. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321:863-868
26. Khoor A, Leslie KO, Tazelaar HO, et al. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol 2001; 115:755-762
27. Ahn CH, McLarty JW, Ahn SS, et al. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982; 125:388-391
28. Marras TK, Wallace RK, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005; 127:664-671
29. Falkinham JO. Mycobacterial aerosols and respiratory disease. Emerg Infect Dis 2003; 9:763-767
30. Doucette K, Fishman JA, Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004; 38:1428-1439
31. Paull DE, Decker GR, Brown RL. Mycobacterium kansasii empyema in a renal transplant recipient: case report and review of the literature. Transplantation 2003; 76:270-271
32. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable lung disease associated with advanced human immunodefiency virus (HIV) infection. Ann Intern Med 1991; 114:861-868
33. Hadjiliadis D, Adlakha A, Prakash UBS. Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc 1999; 74:45-51
34. Kunst H, Wickremasinghe M, Wells A, et al. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir Dis 2006; 28:352-357
35. Tanaka E, Amitani R, Niimi A, et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997; 155:2041-2046
36. Fujita J, Ohtsuki Y, Suemitsu I, et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir Dis 1999; 13:535-540
37. Kobashi Y, Obase Y, Fukuda M, et al. Clinical reevaluation of QuntiFeron TB-2G test as a method for differentiating active tuberculosis from nontuberculosis mycobacteria. Clin Infect Dis 2006; 43:1540-1546
38. Jeong YJ, Lee KS, Koh WJ, et al. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 2004; 231:880-886
39. Obayshi Y, Fujita J, Suemitsu I, et al. Successive follow-up of chest computed tomography in patients with Mycobacterium avium-complex. Respir Med 1999; 93:11-15
40. Tanaka P, Niwatsukino H, Oyama T, et al. Progressing features of atypical mycobacterial infection in the lung on conventional and high resolution CT (HRCT) images. Radiation Med 2001; 19:237-245
41. Koh WJ, Leek S, Kwon OJ, et al. Bilateral bronchiectasis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 2005; 235:282-288
42. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease: incidence, presentation and response to therapy in a community setting. Am Rev Respir Dis 1991; 143:1381-1385
43. Gribetz AR, Damsker B, Bottone EJ, et al. Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med 1981; 70:39-43
44. Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 1989; 149:2201-2205
45. Buckingham SJ, Haddow LJ, Shaw PJ, et al. Immune reconstitution syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol 2004; 59:505-513
46. Maliwan N, Zvetina JR. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Postgrad Med J 2005; 81:530-533
47. Costrini AM, Mahler DA, Gross WM, et al. Clinical and roengenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 1981; 123:104-109
48. The Research Committee of the British Thoracic Scoiety. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-year follow-up of patients receiving standardized treatment. Eur Respir J 2003; 21:478-482
49. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993; 147:1271-1278
50. Wright PW, Wallace RJ, Wright NW, et al. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria. J Clin Microbiolgy 1998; 36:1046-1049
51. Brown-Elliott BA, Griffith DE, Wallace RJ. Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med 2002; 22:911-925
52. Somoskovi A, Mester J, Hale YM, et al. Laboratory diagnosis of nontuberculous mycobacteria. Clin Lab Med 2002; 23:585-597
53. Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J 2005; 26:339-350
54. Tsukamura M. Diagnosis of disease caused by Mycobacterium avium. Chest 1991; 99:667-669
55. Bailey WC. Treatment of atypical mycobacterial disease. Chest 1983; 84:625-628
56. Heifets LB, Iseman MD, Lindholm-Levy PJ. Combinations of rifampin or rifabutin plus ethambutol against Mycobacteriunt avium complex: bactericidal synergistic and bacteriostatic additive or synergistic effects. Am Rev Respir Dis 1988; 137:711-715
57. von Reyn CF, Jacobs NH, Arbeit KD, et al. Polyclonal Mycobacteria avium infections in patients with AIDS: variation in antimicrobial susceptibilities of different strains of M. avium isolates from the same patient. J Clin Microbiol 1995; 33:1008-1010
58. Tsunezuka Y, Sato H, Hiranuma C. Surgical outcome of mycobacterium other than Mycobacterium tuberculosis pulmonary disease. Thorac Cardiovasc Surg 2000; 48:290-293
59. Hanak V, Kalra S, Aksamit TR, et al. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006; 100:610-615
60. Systrom DM, Wittram C. Case 9-2005: a 67 year-old man with acute respiratory failure. N Engl J Med 2005; 352:1238-1246
61. Shitrit D, Baum GL, Priess R, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004. Chest 2006; 129:771-776
62. Ahn CH, Lowell JR, Ahu SA, et al. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. Rev Infect Dis 1981; 3:1028-1034
63. Jenkins PA, Banks J, Campbell IA, et al. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampin and ethambutol. Thorax 1994; 49:442-445
64. Ahn CH, Lowell JR, Ahn SA, et al. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983; 128:1048-1050
65. Griffith DA, Brown-Elliott BA, Wallace RJ Jr. An intermittent clarithromycin (CLARI) containing regimen for Mycobactcrium kansasii. Am J Respir Crit Care Med 2001; 163:762
66. Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 2002; 6:628-634
67. Wallace KJ Jr, Brown BA, Griffith DE, et al. Clarithromycinn regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med 1996; 153:1766-1772
68. Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol and clofazamine. Chest 2003; 124:1482-1486
69. Fujikane T, Fijiuchi S, Yamazaki Y, et al. Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease. Int J Tuberc Lung Dis 2005; 9:1281-1287
70. Tanaka E, Kimoto T, Tsuyuguchi K, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Dis 1999; 160:866-872
71. Griffith DE, Brown BA, Girard WM, et al. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 2001; 32:1547-1553
72. Lam PK, Griffith DE, Aksamit TR, et al. Factors related to response to intermittent treatment for Mycobacterium avium complex lung disease. Am J Respir Crit Care Dis 2006; 173:1283-1289
73. Bermudez LE, Inderlied CB, Kolonoski P, et al. Activity of moxifloxacin by itself and in combination with rifabutin, azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob Agents Chemother 2001; 45:217-222
74. Brown-Elliott BA, Wallace RJ Jr, Blinkhorn R, et al. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001; 33:1433-1444
75. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006; 42:1756-1763